As we enter the second half of 2021, new clinical trials are popping up that are worth keeping an eye one. Today, we round up a few notable trials that will either be starting or releasing results over the coming summer months.
Covid-19 Booster Vaccine Study
The Cov-Boost study has just just announced in May their plans to recruit 2,800 healthy participants across the globe to receive a third booster shot of their Covid-19 vaccine. The study is taking place across 16 sites, with the hopes of determining the safety and efficacy of a booster shot program, and to determine how the different types of Covid-19 vaccines might interact with each other in cases of mixed-vaccination.
MDMA Therapy for PTSD
A recent study by Mitchell et al., published in Nature this past month showed promising results for the use of MDMA in treatment resistant PTSD. In the published study, the authors state “These data indicate that, compared with manualized therapy with inactive placebo, MDMA-assisted therapy is highly efficacious in individuals with severe PTSD, and treatment is safe and well-tolerated, even in those with comorbidities.” The study saw no additional suicidality or adverse effects in the MDMA treated participants, and the results are highly encouraging for further research into the topic of psychoactive drugs for the treatment of severe mental illnesses.
AstraZeneca’s anifrolumab in SLE treatment
AstraZeneca has released results from its analysis of Phase III TULIP clinical trials that assessed anifrolumab in moderate to severe systemic lupus erythematosus (SLE) patients. The study demonstrated significant improvement in skin rash and arthritis symptoms of SLE, when compared to the placebo. Some adverse effects were reported, such as infections of the upper respiratory tract and bronchitis.
Want to learn more?
In addition to reporting clinical trial news and stories from within the patient community, we operate Citrus, a fully integrated recruitment and retention software. Citrus fits any clinical trial and simplifies the implementation of patient engagement in your clinical trial. Whether you are already working with CTMS systems or not, Citrus is the perfect add-on to make patient interaction effective.
Since 2015, our team has been hard at work raising awareness of clinical trials across the globe. A Forbes ‘30 Under 30’ company and a graduate of the renowned Techstar program in New York, Citruslabs is at the forefront of patient recruitment and retention technologies. With over 3 million patients now recorded on our databases, our patient recruitment dashboard is fast becoming the most efficient method of trial recruitment.
Now a #1 health app in 17 countries, our Mindmate app is helping to revolutionize the way we think about healthcare. Mindmate “[takes] senior care into the digital age” (Forbes, 2018) by providing people with the cognitive decline the essential tools to help them rebuild and maintain strong mental health. Trusted by millions of users, our health community continues to grow as the content available expands to the needs of individuals today.
With more than 200 research sites now using the Citrus platform to screen thousands of patients every month, researchers are now well on their way to finding new treatments for hundreds of different health conditions - something that just would not be possible without a technological solution. Make sure that your clinical trial is in the lucky 12% and turn that luck into guaranteed results with Citrus.
Check out what our customers have to say about us here.
And If you’d like to know more about how Citruslabs can help you recruit more effectively, get in touch with our team here.